AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Tiglaz-DM Tablet PR

Prescription Icon
Prescription Required

Marketer

Tas Med India Pvt Ltd

Salt Composition

Metformin (1000mg) + Teneligliptin (20mg)

Overview Tiglaz-DM Tablet PR

Glycemia-Control Duo tablets combine two active agents to manage elevated blood glucose in patients with type 2 diabetes. This dual action helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Glycemia-Control Duo may be used as monotherapy or in conjunction with other antidiabetic treatments. Optimal efficacy requires adherence to a balanced diet and consistent exercise. Dosage is individualized, factoring in your health status, glucose readings, and other medications. Consuming the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Effective blood sugar regulation prevents future complications. Maintaining the prescribed dietary and exercise regimen is crucial. Lifestyle significantly impacts diabetes management. Common side effects include nausea, vomiting, diarrhea, abdominal distress, and cephalgia. Hypoglycemia is a potential adverse effect, especially when co-administered with insulin or sulfonylureas; learn its recognition and management. This medication isn't universally suitable. Inform your physician of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption before initiating treatment. Pregnant or lactating individuals require medical consultation prior to use. Interaction with other medications is possible; disclose all current medications to ensure safety. Alcohol should be limited due to its hypoglycemic effect. Your doctor will monitor renal function and blood glucose levels throughout treatment.

Uses of Tiglaz-DM Tablet PR

Managing type 2 diabetes

Major Benefits of Tiglaz-DM Tablet PR:

Follow your doctor's instructions or consult the product label for dosage information. Take Tiglaz-DM Tablet PR with a meal.

Common Side effects of Tiglaz-DM Tablet PR:

  • Nausea
  • Vomiting
  • Headache
  • Hypoglycemia (low blood glucose level)
  • Diarrhea

How to use Tiglaz-DM Tablet PR:

Follow your physician's instructions or consult the product label for proper administration. Tiglaz-DM Tablet PR should be ingested with a meal.

How Tiglaz-DM Tablet PR works:

Tiglaz-DM PR tablets contain a dual-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Tiglaz-DM Tablet PR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Tiglaz-DM Tablet PR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Tiglaz-DM Tablet PR while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Tiglaz-DM Tablet PR on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Tiglaz-DM Tablet PR with careful consideration; dosage modification may be necessary. Consult your physician for guidance. Tiglaz-DM Tablet PR is contraindicated in individuals with severely compromised kidney function. Close monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Patients with liver conditions should likely not take Tiglaz-DM Tablet PR; its use is discouraged. A physician's advice is recommended.

What if you forget to take Tiglaz-DM Tablet PR :

Should you forget a Tiglaz-DM Tablet PR dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Tiglaz-DM Tablet PR

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Tiglaz-DM Tablet PR

Tiglaz-DM Tablet PR is safe when used as directed by your doctor. However, even with correct dosage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (hypoglycemia) may occur. Hypoglycemia is more likely if you're also using insulin or sulfonylurea. Report any persistent issues to your doctor.
Tiglaz-DM tablets typically don't cause low blood sugar (hypoglycemia) by themselves. However, hypoglycemia can result from inadequate caloric intake while using this medication. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always keep a readily available source of glucose, such as glucose tablets, honey, or fruit juice, on hand.
Nausea and vomiting are possible side effects of Tiglaz-DM Tablet PR. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without medical advice.
Tiglaz-DM Tablet PR is contraindicated in patients allergic to any of its components or excipients. It should also be avoided by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Tiglaz-DM Tablet PR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a rare but serious side effect characterized by excessive blood lactic acid. This risk is heightened in patients with kidney disease, the elderly, and heavy alcohol consumers, thus necessitating avoidance in these groups. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Tiglaz-DM Tablet PR and seek immediate medical attention.
Prolonged Tiglaz-DM Tablet PR use can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency may result in anemia, nerve damage, tingling/numbness in extremities, weakness, urinary issues, cognitive changes, and balance problems (ataxia). Report any such symptoms to your doctor, who may recommend vitamin B12 level monitoring and supplementation.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Tiglaz-DM Tablet PR
100
MRP 122
17% off